New Genomic Techniques Regulation
What it says — in plain language
Plants edited with "new genomic techniques" (such as CRISPR) would be split into two categories. Category 1: up to 20 genetic modifications of types that could occur naturally or through conventional breeding — treated like conventional plants: no GMO risk assessment, no traceability obligations, no GMO label on the final food product (seeds still labelled). Category 2: everything else stays under the existing GMO Directive. Member states could not ban Category 1 crops on their territory. The final text was adopted by the European Parliament on 17 June 2026. A two-year implementation period now begins, during which the Commission develops the secondary legislation and implementing acts.
COM(2023) 411 final, Articles 4-5 & Annex I · EP position of 7 Feb 2024, Amendment 35
Lens 1 · Highly critical — how could this be used for harm?
Removing the consumer label means an Irish shopper cannot choose to avoid gene-edited food; the information exists at seed level but vanishes by the supermarket shelf. The 20-edit threshold was set by negotiation, not published safety evidence. If Category 1 status is granted on developer-submitted data, the companies that profit from a crop supply the case for deregulating it. Member states losing the right to ban cultivation removes Ireland's national opt-out, and unresolved patent questions could concentrate seed ownership in a small number of agrochemical firms.
Lens 2 · Highly optimistic — how could this improve life for EU citizens?
Gene editing can produce blight-resistant potatoes — in Ireland, that means fewer of the roughly 10–15 fungicide sprays applied per season. Crops needing less water and fertiliser lower emissions and farm costs. The current GMO regime dates from 2001 and makes field trials so slow that research has moved to the US and China; this would let European (including Irish, via Teagasc) science compete. Faster development of climate-adapted varieties matters as growing conditions shift.
Lens 3 · Plain-language impact — your day, your wallet
Bread, beer, frozen chips: within a few years, ingredients from gene-edited crops could be in everyday products without a label saying so. Food prices could fall slightly if resistant varieties cut input costs. If you buy organic, certified organic food remains NGT-free — that becomes the only guaranteed avoidance route. For farmers: access to new varieties, but watch the patent question, which decides whether saving seed remains legal.
Lens 4 · Who benefits / who pays
Benefit: seed and agrochemical companies (Bayer, Corteva, BASF hold most NGT patent applications), large arable farms, plant-science institutes. Pay: the organic sector (coexistence and contamination-testing costs fall on them), non-GMO certifiers, and consumers who lose point-of-sale choice. Member-state split: Ireland, the Netherlands and the Nordics broadly support; Austria and Hungary oppose.
Lens 5 · Sovereignty check — what moves from Dublin to Brussels
As a Regulation, it applies directly — no Dáil transposition vote. Ireland's current right to restrict GMO cultivation under Directive 2015/412 would not apply to Category 1 plants: that decision moves permanently to EU level. The Oireachtas's influence points are the Minister's vote in Council and Irish MEPs in the final plenary vote. After that, no Irish institution can reverse it.
The Tally — your verified vote
On the record
This file has been decided. The window to influence it has closed — but the vote is now permanent public record, and how your representatives voted is what the scorecards will hold them to.
See how they voted